Why the study?
Is insulin resistance or obstructive sleep apnea associated with hepatic steatosis in Chinese patients with severe obesity?
Is insulin resistance or obstructive sleep apnea associated with hepatic steatosis in Chinese patients with severe obesity?
Insulin resistance (HOMA-IR), rather than obstructive sleep apnea severity (AHI), is an independent risk factor for hepatic steatosis in Chinese patients with severe obesity.
HOMA-IR may aid steatosis risk stratification beyond AHI in severe obesity; hypothesis-generating and requires prospective validation.
Prevalence of OSA and NAFLD was high in patients with obesity eligible for bariatric procedures. HOMA-IR, but not AHI, was an independent risk factor for hepatic steatosis in this population.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2023) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: